Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine immunogenicity varies between individuals, and immune responses correlate with vaccine efficacy. Using data from 1,076 participants enrolled in ChAdOx1 nCov-19 vaccine efficacy trials in the United Kingdom, we found that inter-individual variation in normalized antibody responses against SARS-CoV-2 spike and its receptor-binding domain (RBD) at 28 days after first vaccination s…

FDA Criticized For COVID-19 Jab Announcement * 100PercentFedUp.com * by Danielle

As the FDA prepares for a pivotal meeting on COVID-19 vaccine formulas, backlash is brewing over its recent announcement. Discover the implications of these discussions and what they mean for future vaccination guidelines.

FDA to Meet on COVID-19 Vaccines

Food and Drug Administration (FDA) officials are going to meet soon to consider the next round of COVID-19 vaccines, the agency said on May 7. The FDA plans to convene its vaccine advisory panel for a virtual meeting on May 22. The Vaccines and Related Biological Products Advisory Committee “will meet in an open session to discuss and make recommendations on the selection of the 2025-2026 Formula for COVID-19 vaccines for use in the United State…

Quick takes: FDA advisers to weigh COVID vaccines, H5N1 in US cows and poultry

The WHO's advisory group will also weigh in on COVID vaccine composition this month.